• Patient Resource Type

  • PDF

Displaying results 1 - 12 of 31

Display:

12 24 48

Public Health and Advocacy

EASL Policy Statement on the Coexistence of Non-Alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease - FR

PDF

View

Public Health and Advocacy

EASL Policy Statement on the Coexistence of Non-Alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease - GE

PDF

View

Public Health and Advocacy

EASL Policy Statement on the Coexistence of Non-Alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease - CZ

PDF

View

Public Health and Advocacy

EASL Policy Statement on Hepatitis C Elimination - GE

PDF

View

Public Health and Advocacy

EASL Policy Statement on Drug Use and the Global Hepatitis C Elimination Goal - RU

PDF

View

Public Health and Advocacy

EASL Policy Statement on Drug Use and the Global Hepatitis C Elimination Goal - CZ

PDF

View

Public Health and Advocacy

EASL Policy Statement on the Coexistence of Non-Alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease - EN

PDF

View

COVID-19 and the liver

EASL Policy Statement on the Use of COVID-19 Vaccines in People with Chronic Liver Disease, Hepatobiliary Cancer, and Liver Tr...

PDF

View

Public Health and Advocacy

EASL Policy Statement on Hepatitis C Elimination - SP

PDF

View

Public Health and Advocacy

EASL Policy Statement on Liver Cancer Screening

PDF

View

Public Health and Advocacy

EASL Policy Statement on Obesity is Feeding the Rise in Non-Alcoholic Fatty Liver Disease (NAFLD) across Europe

PDF

View

Public Health and Advocacy

EASL Policy Statement on Liver Disease and Migrant Health

PDF

View

Displaying results 1 - 12 of 31

Display:

12 24 48